BAMCO Inc’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,292,998
| Closed | -$223M | – | 437 |
|
|
2021
Q3 | $223M | Sell |
1,292,998
-9,277
| -0.7% | -$1.21M | 0.5% | 47 |
|
|
2021
Q2 | $163M | Buy |
1,302,275
+163,972
| +14% | +$20.7M | 0.37% | 64 |
|
|
2021
Q1 | $154M | Buy |
1,138,303
+90,260
| +9% | +$11.7M | 0.38% | 60 |
|
|
2020
Q4 | $134M | Buy |
1,048,043
+162,568
| +18% | +$19.1M | 0.33% | 69 |
|
|
2020
Q3 | $99.6M | Buy |
885,475
+466,397
| +111% | +$46.4M | 0.31% | 71 |
|
|
2020
Q2 | $39.9M | Buy |
419,078
+113,335
| +37% | +$10.9M | 0.14% | 123 |
|
|
2020
Q1 | $27.5M | Sell |
305,743
-14,857
| -5% | -$1.15M | 0.13% | 122 |
|
|
2019
Q4 | $17M | Buy |
320,600
+27,766
| +9% | +$1.27M | 0.06% | 173 |
|
|
2019
Q3 | $11.6M | Buy |
292,834
+91,450
| +45% | +$3.97M | 0.05% | 198 |
|
|
2019
Q2 | $8.27M | Buy |
201,384
+80,707
| +67% | +$3.34M | 0.03% | 232 |
|
|
2019
Q1 | $5.62M | Buy |
120,677
+50,446
| +72% | +$2.21M | 0.02% | 247 |
|
|
2018
Q4 | $3.06M | Buy |
70,231
+928
| +1% | +$46.4K | 0.02% | 266 |
|
|
2018
Q3 | $3.97M | Buy |
69,303
+2,425
| +4% | +$119K | 0.02% | 263 |
|
|
2018
Q2 | $3.25M | Buy |
66,878
+10,063
| +18% | +$367K | 0.01% | 258 |
|
|
2018
Q1 | $2.22M | Buy |
56,815
+2,935
| +5% | +$125K | 0.01% | 268 |
|
|
2017
Q4 | $2.29M | Buy |
53,880
+8,700
| +19% | +$326K | 0.01% | 272 |
|
|
2017
Q3 | $1.69M | Buy |
45,180
+142
| +0.3% | +$4.93K | 0.01% | 281 |
|
|
2017
Q2 | $1.37M | Buy |
+45,038
| New | +$1.31M | 0.01% | 295 |
|